Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Change in Inventory (2023 - 2024)

Historic Change in Inventory for Seres Therapeutics (MCRB) over the last 2 years, with Q3 2024 value amounting to $10.4 million.

  • Seres Therapeutics' Change in Inventory fell 2078.12% to $10.4 million in Q3 2024 from the same period last year, while for Jun 2025 it was $10.4 million, marking a year-over-year decrease of 7808.3%. This contributed to the annual value of $33.8 million for FY2024, which is 1399.13% up from last year.
  • Latest data reveals that Seres Therapeutics reported Change in Inventory of $10.4 million as of Q3 2024, which was down 2078.12% from $11.0 million recorded in Q2 2024.
  • Over the past 5 years, Seres Therapeutics' Change in Inventory peaked at $13.2 million during Q3 2023, and registered a low of $5.3 million during Q2 2023.